Celiac disease associated with significant economic burden

Patients with celiac disease incurred higher all-cause direct costs compared with non-celiac patients, especially those with uncontrolled celiac disease, according to data presented Digestive Disease Week. “There have been few previous studies evaluating the cost burden associated with celiac disease,” Stefano Guandalini, MD, from University of Chicago, said in a presentation. “Clearly, studies are needed to assess health care costs among patients with controlled and uncontrolled celiac disease … to better understand what factors drive excess costs.”